Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Abliva Total Assets (Quarterly): 8.692M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.692M |
| September 30, 2023 | 9.986M |
| June 30, 2023 | 13.08M |
| March 31, 2023 | 15.13M |
| December 31, 2022 | 17.64M |
| September 30, 2022 | 18.29M |
| June 30, 2022 | 17.87M |
| March 31, 2022 | 6.679M |
| December 31, 2021 | 6.513M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 21.49M |
| March 31, 2021 | 15.72M |
| December 31, 2020 | 12.08M |
| September 30, 2020 | 18.12M |
| June 30, 2020 | 17.20M |
| March 31, 2020 | 11.96M |
| December 31, 2019 | 15.89M |
| September 30, 2019 | 17.40M |
| June 30, 2019 | 20.48M |
| March 31, 2019 | 22.02M |
| December 31, 2018 | 12.84M |
| September 30, 2018 | 14.60M |
| June 30, 2018 | 16.04M |
| March 31, 2018 | 12.98M |
| December 31, 2017 | 14.69M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.26M |
| June 30, 2017 | 15.96M |
| March 31, 2017 | 17.34M |
| December 31, 2016 | 19.93M |
| September 30, 2016 | 22.51M |
| June 30, 2016 | 26.77M |
| March 31, 2016 | 20.87M |
| December 31, 2015 | 20.80M |
| September 30, 2015 | 22.81M |
| June 30, 2015 | 28.97M |
| March 31, 2015 | 22.89M |
| December 31, 2014 | 16.93M |
| September 30, 2014 | 18.47M |
| June 30, 2014 | 20.28M |
| March 31, 2014 | 23.98M |
| December 31, 2013 | 13.91M |
| September 30, 2013 | 9.150M |
| June 30, 2013 | 9.548M |
| March 31, 2013 | 10.19M |
| December 31, 2012 | 11.00M |
| September 30, 2012 | 11.18M |
| June 30, 2012 | 11.14M |
| March 31, 2012 | 4.966M |
| December 31, 2011 | 4.908M |
| September 30, 2011 | 5.273M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.513M
Minimum
Dec 2021
21.49M
Maximum
Jun 2021
14.50M
Average
15.72M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Karolinska Development AB | 118.29M |
| Calliditas Therapeutics AB | 184.69M |
| Oncopeptides AB | 27.02M |
| Olink Holding AB | 602.25M |
| BioInvent International AB | 124.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.667M |
| Shareholders Equity (Quarterly) | 7.025M |
| Current Ratio | 3.800 |